The use of microfluidics in hemostasis: Clinical diagnostics and biomimetic models of vascular injury

Current Opinion in Hematology

Volumn 20, Issue 5, 2013, Pages 417-423

  Neeves, Keith B ^a,b   Onasoga, Abimbola A ^a   Wufsus, Adam R ^a  

^a Department of Geology and Geological Engineering   (United States)

^b Nutrition Obesity Research Center at the University of Colorado   (United States)

Author keywords

biorheology; coagulation; endothelium; microfluidics; platelets

Indexed keywords

VON WILLEBRAND FACTOR;

BIOMIMETICS; BLOOD CLOTTING; BLOOD VESSEL INJURY; HEMOSTASIS; MICROFLUIDICS; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

BIOMIMETICS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; THROMBOSIS; VASCULAR DISEASES;

EID: 84883264594     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283642186     Document Type: Review

References (53)

1. Sakariassen KS, Turitto VT, Baumgartner HR. Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood. J Thromb Haemost 2004; 2:1681-1690.
2. Zwaginga JJ, Sakariassen KS, King MR, et al. Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3? J Thromb Haemost 2007; 5:2547-2549.
3. Roest M, Reininger A, Zwaginga JJ, et al., the Biorheology Subcommittee of the SSC of the ISTH. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J Thromb Haemost 2011; 9:2322-2324.
4. Prabhakarpandian B, Shen M-C, Pant K, Kiani MF. Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. Microvasc Res 2011; 82:210-220.
5. Westein E, De Witt S, Lamers M, et al. Monitoring in vitro thrombus formation with novel microfluidic devices. Platelets 2012; 23:501-509.
6. Hansen RR, Wufsus AR, Barton ST, et al. High content evaluation of shear dependent platelet function in a microfluidic flow assay. Ann Biomed Eng 2013; 41:250-262.
7. Gutierrez E, Petrich BG, Shattil SJ, et al. Microfluidic devices for studies of shear-dependent platelet adhesion. Lab Chip 2008; 8:1486-1495.
8. Neeves KB, Maloney SF, Fong KP, et al. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J Thromb Haemost 2008; 6:2193-2201.
9. Zhu L, Stalker T, Fong K, et al. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscl Thromb Vasc Biol 2009; 29:1039-1045.
10. Schmaier AA, Zou Z, Kazlauskas A, et al. Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc Natl Acad Sci U S A 2009; 106:21167-21172.
11. Wannemacher K, Zhu L, Jiang H, et al. Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 2010; 116:5707.
12. Lisman T, Adelmeijer J, Cauwenberghs S, et al. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost 2005; 3:742-751.
13. Cosemans J, Schols S, Stefanini L, et al. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 2011; 117:651.
14. White TC, Berny MA, Tucker EI, et al. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost 2008; 6:995-1002.
15. Tseng P-Y, Rele SS, Sun X-L, Chaikof EL. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model. Biomaterials 2006; 27:2637-2650.
16. Kastrup C, Shen F, Runyon M, Ismagilov R. Characterization of the threshold response of initiation of blood clotting to stimulus patch size. Biophys J 2007; 93:2969-2977.
17. Haynes LM, Dubief YC, Orfeo T, Mann KG. Dilutional control of prothrombin activation at physiologically relevant shear rates. Biophy J 2011; 100:765-773.
18. Runyon M, Kastrup C, Johnson-Kerner B, et al. Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J Am Chem Soc 2008; 130:3458-3464.
19. Shen F, Kastrup CJ, Liu Y, Ismagilov RF. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler Thromb Vasc Biol 2008; 28:2035-2041.
20. Kastrup CJ, Runyon MK, Shen F, Ismagilov RF. From the cover: modular chemical mechanism predicts spatiotemporal dynamics of initiation in the complex network of hemostasis. Proc Natl Acad Sci U S A 2006; 103:15747-15752.
21. Neeves KB, Diamond SL. A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood. Lab Chip 2008; 8:701-709.
22. Neeves KB, Illing DAR, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 2010; 98:1344-1352.
23. Okorie UM, Denney WS, Chatterjee MS, et al. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 2008; 111:3507-3513.
24. Colace TV, Jobson J, Diamond SL. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Bioconjugate Chem 2011; 22:2104-2109.
25. Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 2012; 32:1466-1476.
26. Muthard RW, Diamond SL. Blood clots are rapidly assembled hemodynamic sensors: flow arrest triggers intraluminal thrombus contraction. Arterioscler Thromb Vasc Biol 2012; 32:2938-2945.
27. Young EWK, Simmons CA. Macro- and microscale fluid flow systems for endothelial cell biology. Lab Chip 2010; 10:143.
28. Conant CG, Nevill JT, Zhou Z, et al. Using well plate microfluidic devices to conduct shear-based thrombosis assays. Jala-J Lab Autom 2011; 16:148-152.
29. Conant CG, Schwartz MA, Beecher JE, et al. Well plate microfluidic system for investigation of dynamic platelet behavior under variable shear loads. Biotechnol Bioeng 2011; 108:2978-2987.
30. Nissinen L, Pentikäinen OT, Jouppila A, et al. A small-molecule inhibitor of integrin a2 b1 introduces a new strategy for antithrombotic therapy. Thromb Haemost 2010; 103:387-397.
31. Philipose S, Konya V, Sreckovic I, et al. The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol 2010; 30:2416.
32. Okorie UM, Diamond SL. Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow. Biophys J 2006; 91:3474-3481.
33. Nalayanda DD, Kalukanimuttam M, Schmidtke DW. Micropatterned surfaces for controlling cell adhesion and rolling under flow. Biomed Microdevices 2007; 9:207-214.
34. Maloney SF, Brass LF, Diamond SL. P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr Biol 2010; 2:183.
35. Hosokawa K, Ohnishi T, Kondo T, et al. A novel automated microchip flowchamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost 2011; 9:2029-2037.
36. Ogawa S, Szlam F, Dunn AL, et al. Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and antifactor IXa-treated human blood. Haemophilia 2012; 18:926-932.
37. Li M, Ku DN, Forest CR. Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood. Lab Chip 2012; 12:1355.
38. Neeves KB, Onasoga AA, Hansen RR, et al. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One 2013; 8:e54680.
39. Roest M, Sixma JJ, Wu YP, et al. Platelet adhesion to collagen in healthy volunteers is influenced by variation of both alpha(2)beta(1) density and von Willebrand factor. Blood 2000; 96:1433-1437.
40. Heemskerk JWM, Sakariassen KS, Zwaginga JJ, et al. Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost 2011; 9:856-858.
41. Savage B, Ginsberg MH, Ruggeri ZM. Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 1999; 94:2704-2715.
42. Pugh N, Simpson AMC, Smethurst PA, et al. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 2010; 115:5069-5079.
43. Hansen RR, Tipnis AA, White-Adams TC, et al. Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion. Langmuir 2011; 27:13648-13658.
44. Tsai M, Kita A, Leach J, et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 2011; 122:408-418.
45. Rosano JM, Tousi N, Scott RC, et al. A physiologically realistic in vitro model of microvascular networks. Biomed Microdevices 2009; 11:1051-1057.
46. Zheng Y, Chen J, Craven M, et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci U S A 2012; 109:9342-9347.
47. Nesbitt W, Westein E, Tovar-Lopez F, et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15:665-673.
48. Tovar-Lopez FJ, Rosengarten G, Westein E, et al. A microfluidics device to monitor platelet aggregation dynamics in response to strain rate microgradients in flowing blood. Lab Chip 2010; 10:291.
49. Westein E, van derMeer AD, KuijpersMJE, et al. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc Natl Acad Sci U S A 2013; 110: 1357-1362.
50. Korin N, Kanapathipillai M, Matthews BD, et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 2012; 337:738-742.
51. Sarvepalli DP, Schmidtke DW, Nollert MU. Design considerations for a microfluidic device to quantify the platelet adhesion to collagen at physiological shear rates. Ann Biomed Eng 2009; 37:1331-1341.
52. Kent NJ, O'Brien S, Basabe-Desmonts L, et al. Shear-mediated platelet adhesion analysis in less than 100mL of blood: toward a POC platelet diagnostic. IEEE Trans Biomed Eng 2011; 58:826-830.
53. Ku D. Blood flow in arteries. Annul Rev Fluid Mechanics 1997; 29:399-434.